Tulane University School of Medicine
Professor of Medicine and Pharmacology
Tullis-Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Prevention and treatment of type 2 diabetes and complications
Dr. Fonseca has a bachelor of medicine and bachelor of surgery from the Armed Forces Medical College in Poona, India, and earned his MD from Bombay University, India. He completed residency training in Internal Medicine at the Royal Free Hospital in London, England along with a fellowship in endocrinology with the National Health Service. Between 1992 and 1998 he was Faculty in the Division of Endocrinology at the University of Arkansas for Medical Sciences, Little Rock. Since 1998 he is Professor of Medicine, Tullis –Tulane Alumni Chair in Diabetes, Section of Endocrinology at Tulane University Health Sciences Center. Over the course of his career Dr. Fonseca has conducted trial for most diabetes drugs on the market. Dr. Fonseca is the past President of Medicine & Science for the American Diabetes Association. He is editor-in-chief of the Journal of Diabetes Complications. Between 2007 and 2012, he was editor in chief of Diabetes Care, having formerly been associate editor. He was until 2006 editor-in-chief of the Journal of the Metabolic Syndrome and related disorders. He served on the editorial board of the Journal of Clinical Endocrinology and Metabolism (2003-2006). He is an ad hoc reviewer for several other journals including New England Journal of Medicine, JAMA, Diabetes, Diabetic Medicine, Kidney International, the American Journal of Clinical Nutrition, the British Medical Journal, and Metabolism. Dr. Fonseca is a fellow of the Royal College of Physicians, the American Association of Clinical Endocrinologists and the American College of Physicians. He is a member of the Endocrine Society, the American Diabetes Association, and the International Diabetes Federation. He serves on several national and international committees, and has published over 200 papers, review articles and book chapters. He is the editor of the text book "Clinical Diabetes: Translating Research into Practice" (Elsevier 2006). In 2012 he received the American Diabetes Association Banting Medal for leadership and service.
Dr. Fonseca's current research interests include the prevention and treatment of diabetic complications and risk factor reduction in cardiovascular disease. He has a research program evaluating homocysteine and inflammation as risk factors for heart disease in diabetes. He is currently the principal investigator of the DRMS (diabetes remote management system) study, a study aimed at evaluating the effectiveness and possibilities of using a remote technology system to enhance and manage daily care for patients with Type 2 Diabetes Mellitus. Dr. Fonseca is also the principal investigator of the Zemplar study, a study investigating the effects of Zemplar (paricalcitol) on endothelial function and inflammation in patients with Type 2 Diabetes Mellitus and stage 3 or 4 chronic kidney disease.
He is also the principal investigator of the ACCORDION study, an NIH sponsored, multicenter follow –up study to the ACCORD study which examined cardiovascular risk and diabetes. Dr. Fonseca is also the principal investigator for the BEACON study, a multicenter study evaluating the effects of bardoxolone methyl in patients with chronic kidney disease and Type 2 diabetes.
1430 Tulane Ave, New Orleans, LA 70112 504-988-5331 email@example.com